Det verkar som ett fel inträffade när du försökte ladda denna sida.
Vårt team har meddelats men vänligen kontakta oss via widget för e-postsupport om problemet kvarstår.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | No | No |
| Competitors Used |
|---|
| AstraZeneca Pharma India Limited |
| GlaxoSmithKline Pharmaceuticals Limited |
| Medico Remedies Limited |
| Abbott India Limited |
| Pfizer Limited |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 506,820 | 500,660 | 540,937 | 500,488 | 500,680 | 500,672 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | NA | NA | NA | NA | NA | NA | ||
| Fiscal Year - 1 | 18% | 28% | 18% | 32% | 21% | 14% | ||
| Fiscal Year - 2 | 13% | 18% | 14% | 29% | 23% | -1% | ||
| Fiscal Year - 3 | 23% | 17% | 8% | 27% | 17% | 3% | ||
| Fiscal Year - 4 | 22% | 5% | 6% | 27% | 16% | 1% | ||
| Fiscal Year - 5 | 20% | 21% | 6% | 24% | 15% | 7% | ||
| Average | 19% | 18% | 10% | 28% | 18% | 5% | ||
| Median | 20% | 18% | 8% | 27% | 17% | 3% | ||
| Benchmarks | Ticker | |||||||
| AstraZeneca Pharma India Limited | BSE:506820 | |||||||
| GlaxoSmithKline Pharmaceuticals Limited | BSE:500660 | |||||||
| Medico Remedies Limited | BSE:540937 | |||||||
| Abbott India Limited | BSE:500488 | |||||||
| Pfizer Limited | BSE:500680 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Aug-87 | Oct-70 | Jan-81 | Apr-70 | Oct-70 | Oct-70 | ||
| Latest Fiscal Year | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 16,190 | 37,046 | 1,510 | 62,432 | 22,361 | 3,536 | ||
| Fiscal Year | 12,955 | 34,537 | 1,449 | 58,489 | 21,932 | 3,351 | ||
| Fiscal Year - 1 | 10,030 | 32,517 | 1,404 | 53,487 | 24,248 | 3,787 | ||
| Fiscal Year - 2 | 8,056 | 32,780 | 1,210 | 49,133 | 26,110 | 3,999 | ||
| Fiscal Year - 3 | 8,136 | 29,256 | 1,224 | 43,100 | 22,404 | 3,814 | ||
| Fiscal Year - 4 | 8,318 | 32,244 | 886 | 40,931 | 21,517 | 4,383 | ||
| Fiscal Year - 5 | 7,283 | 31,281 | 977 | 36,786 | 20,815 | 4,907 | ||
| Net Income | ||||||||
| Latest Twelve Months | 970 | 8,592 | 89 | 13,345 | 6,155 | 863 | ||
| Fiscal Year | 1,615 | 5,900 | 83 | 12,012 | 5,513 | 852 | ||
| Fiscal Year - 1 | 993 | 6,076 | 72 | 9,494 | 6,239 | 1,034 | ||
| Fiscal Year - 2 | 616 | 3,808 | 48 | 7,987 | 6,126 | (37) | ||
| Fiscal Year - 3 | 933 | 2,873 | 26 | 6,907 | 4,976 | 209 | ||
| Fiscal Year - 4 | 722 | 932 | 16 | 5,929 | 5,091 | 101 | ||
| Fiscal Year - 5 | 545 | 4,454 | 16 | 4,503 | 4,291 | 518 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | NA | NA | NA | NA | NA | NA | ||
| Latest Fiscal Quarter | NA | NA | NA | NA | NA | NA | ||
| Fiscal Year | 10,780 | 35,566 | 962 | 51,935 | 42,288 | 9,249 | ||
| Fiscal Year - 1 | 9,849 | 33,266 | 874 | 45,555 | 40,007 | 9,829 | ||
| Fiscal Year - 2 | 8,566 | 46,333 | 774 | 42,241 | 39,005 | 9,576 | ||
| Fiscal Year - 3 | 7,747 | 31,146 | 756 | 38,405 | 32,659 | 10,023 | ||
| Fiscal Year - 4 | 7,064 | 31,332 | 753 | 35,469 | 44,054 | 10,776 | ||
| Fiscal Year - 5 | 5,618 | 39,113 | 763 | 29,409 | 39,400 | 9,824 | ||
| Fiscal Year - 6 | 4,605 | 39,475 | 594 | 24,162 | 36,900 | 11,105 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 6,550 | 15,396 | 476 | 31,089 | 32,730 | 7,023 | ||
| Latest Fiscal Quarter | 6,794 | 16,727 | 555 | 35,211 | 37,509 | 7,292 | ||
| Fiscal Year | 7,119 | 17,776 | 524 | 36,989 | 35,955 | 7,448 | ||
| Fiscal Year - 1 | 5,887 | 17,413 | 438 | 31,885 | 32,073 | 7,757 | ||
| Fiscal Year - 2 | 5,114 | 26,630 | 366 | 28,198 | 28,644 | 6,917 | ||
| Fiscal Year - 3 | 4,562 | 14,783 | 325 | 26,022 | 23,930 | 7,112 | ||
| Fiscal Year - 4 | 3,644 | 18,206 | 299 | 24,317 | 33,955 | 7,207 | ||
| Fiscal Year - 5 | 3,008 | 21,398 | 282 | 20,086 | 30,113 | 7,592 | ||
| Fiscal Year - 6 | 2,469 | 20,573 | 267 | 16,928 | 26,832 | 7,336 | ||